表紙
市場調查報告書

免疫譜表測序的全球市場:各產品種類、各用途、各終端用戶、各地區 - 產業考察,市場趨勢、展望、機會分析

Immune Repertoire Sequencing Market, by Product Type (Instruments, and Reagents and Kits), by Application, by End User, and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 -2025

出版商 Coherent Market Insights 商品編碼 798068
出版日期 內容資訊 英文 200 Pages
商品交期: 2-3個工作天內
價格
Back to Top
免疫譜表測序的全球市場:各產品種類、各用途、各終端用戶、各地區 - 產業考察,市場趨勢、展望、機會分析 Immune Repertoire Sequencing Market, by Product Type (Instruments, and Reagents and Kits), by Application, by End User, and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 -2025
出版日期: 2019年02月01日內容資訊: 英文 200 Pages
簡介

本報告提供全球免疫技能範圍專攻領域定序的市場相關分析,技術概要,及市場基本結構及促進、阻礙因素,整體市場規模預測,各產品種類、各用途、各終端用戶、各地區的詳細趨勢,主要企業的簡介,產業相關人員今後應致力處理的課題等調查。

第1章 分析目的、前提條件

第2章 市場概況

  • 分析概要
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響度分析
  • 市場趨勢
  • 市場主要趨勢
  • 法規環境
  • 產品的回收
  • 流行病學的分析
  • 技術概要
  • PEST分析
  • 波特的五力分析

第4章 免疫技能範圍專攻領域定序市場:各產品種類

  • 簡介
    • 市場佔有率分析 (最新值、預測值)
    • 市場成長率分析 (總計10年份)
    • 各部門分析
  • 化驗套件
    • 簡介
    • 市場規模、年度成長率與其預測 (以金額為準,今後9年份)
    • T細胞受體 (TCR) 套件
    • B細胞受體 (BCR) 套件
  • 測量設備

第5章 免疫技能範圍專攻領域定序市場:各用途

  • 簡介
  • 癌症免疫療法
  • 生物標記探索
  • 自體免疫疾病
  • 疫苗開發、功效
  • 移植排斥反應、抗性
  • 感染疾病
  • 其他的用途

第6章 免疫技能範圍專攻領域定序市場:各終端用戶

  • 簡介
  • 臨床檢驗室
  • 生物科技/製藥企業
  • 教育、研究機關
  • 其他

第7章 免疫技能範圍專攻領域定序市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
    • 市場規模與其預測:各產品種類 (以金額為準,今後9年份)
    • 市場規模與其預測:各用途 (以金額為準,今後9年份)
    • 市場規模與其預測:各終端用戶 (以金額為準,今後9年份)
    • 市場規模與其預測:各國 (以金額為準,今後9年份)
  • 歐洲 (英國,德國,義大利,法國,西班牙,俄羅斯等)
  • 亞太地區 (中國,日本,印度,東南亞國協,澳洲,韓國等)
  • 南美 (巴西,墨西哥,阿根廷等)
  • 非洲 (北部/中部/非洲南部)
  • 中東 (波灣合作理事會 (GCC) 各國,以色列等)

第8章 競爭環境

  • 企業簡介
    • Thermo Fisher Scientific, Inc.
      • 企業概要
      • 產品簡介
      • 財務成果
      • 近幾年的主要趨勢
      • 策略
    • Illumina Inc.
    • ArcherDX, Inc.
    • Roche Holding AG
    • Pacific Biosciences
    • CD Genomics
    • Atreca, Inc.
    • Adaptive Biotechnologies
    • Oxford Nanopore Technologies, Ltd.
    • Qiagen N.V.
    • Agilent Technologies, Inc.
    • TaKaRa BIO
  • 分析師的見解

第9章 附錄

目錄

Immune repertoire refers to sub-type protein that an organism's immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Market Dynamics

Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.

However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.

Key features of the study:

  • This report provides in-depth analysis of the immune repertoire sequencing market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global immune repertoire sequencing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation

  • Global Immune Repertoire Sequencing Market, By Product Type:
    • Assay Kits
      • T-Cell Receptor (TCR) Kits
      • B-Cell Receptor (BCR) Kits
    • Instruments
  • Global Immune Repertoire Sequencing Market, By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
  • Global Immune Repertoire Sequencing Market, By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Others
  • Global Immune Repertoire Sequencing Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
  • Company Profiles
    • Thermo Fisher Scientific, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Illumina Inc.
    • ArcherDX, Inc
    • Roche Holding AG
    • Pacific Biosciences
    • CD Genomics
    • Atreca, Inc.
    • Adaptive Biotechnologies
    • Oxford Nanopore Technologies, Ltd.
    • Qiagen N.V.
    • Agilent Technologies, Inc.
    • Takara Bio, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Landscape
  • Product Recall
  • Epidemiology Analysis
  • Technology Overview
  • PEST Analysis
  • Porter's Five Forces model

4. Global Immune Repertoire Sequencing Market, By Product Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Assay Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • T-Cell Receptor (TCR) Kits
    • B-Cell Receptor (BCR) Kits
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

5. Global Immune Repertoire Sequencing Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Cancer Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Biomarker Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Autoimmune Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Vaccine Development and Efficacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Transplant Rejection and Tolerance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

6. Global Immune Repertoire Sequencing Market, By End User, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Diagnostic Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

7. Global Immune Repertoire Sequencing Market, By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Illumina Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • ArcherDX, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Roche Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pacific Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • CD Genomics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Atreca, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Adaptive Biotechnologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Oxford Nanopore Technologies, Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Agilent Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Takara Bio, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top